David B. Yaden
Johns Hopkins University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name David B. Yaden as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 06:46 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT07610135 · Psilocybin Efficacy With or Without Pimavanserin PretreatmentJohns Hopkins University · recruiting · Mood (Psychological Function), Well Being, Mood · principal investigator
- Ph1NCT06355414 · Psilocybin in Chronic Low Back Pain and DepressionJohns Hopkins University · recruiting · Chronic Low-back Pain, Depression
- Early Ph1NCT05546658 · Effects of Psilocybin in Obsessive Compulsive DisorderJohns Hopkins University · active not recruiting · Obsessive-Compulsive Disorder
Grants
NIH projects from RePORTER, fetched 2026-11-12 06:46 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Psilocybin and Affective Function in Chronic Lower Back Pain and DepressionR33AT012317 · NCCIH · JOHNS HOPKINS UNIVERSITY · fiscal years 2023 to 2025 · $511,903 awarded in 2025Grant number is on one of their registry trials
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 06:46 UTC. The ranking covers the 200 most relevant of 1 PubMed records, and a shared surname and initials can bring in a namesake. All 1 on PubMed